Cargando…

The Shortening of Leukocyte Telomere Length Contributes to Alzheimer’s Disease: Further Evidence from Late-Onset Familial and Sporadic Cases

SIMPLE SUMMARY: Alzheimer’s disease (AD) is one of the most common forms of dementia in the aging population. The shortening of telomeres, which are complex structures at the ends of chromosomes, is considered one of the hallmarks of aging and has been implicated in several neurodegenerative disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Crocco, Paolina, De Rango, Francesco, Dato, Serena, La Grotta, Rossella, Maletta, Raffaele, Bruni, Amalia Cecilia, Passarino, Giuseppe, Rose, Giuseppina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604697/
https://www.ncbi.nlm.nih.gov/pubmed/37886996
http://dx.doi.org/10.3390/biology12101286
_version_ 1785126897792843776
author Crocco, Paolina
De Rango, Francesco
Dato, Serena
La Grotta, Rossella
Maletta, Raffaele
Bruni, Amalia Cecilia
Passarino, Giuseppe
Rose, Giuseppina
author_facet Crocco, Paolina
De Rango, Francesco
Dato, Serena
La Grotta, Rossella
Maletta, Raffaele
Bruni, Amalia Cecilia
Passarino, Giuseppe
Rose, Giuseppina
author_sort Crocco, Paolina
collection PubMed
description SIMPLE SUMMARY: Alzheimer’s disease (AD) is one of the most common forms of dementia in the aging population. The shortening of telomeres, which are complex structures at the ends of chromosomes, is considered one of the hallmarks of aging and has been implicated in several neurodegenerative diseases, especially AD, where the results are conflicting. Thus, to help clarify the association of telomere length with AD risk, leukocyte telomere length (LTL), measured as T/S ratio (telomere vs single-copy gene) was assessed in a cohort of 534 subjects, comprising sporadic and familial cases of late-onset AD (LOAD) and cognitively healthy controls. Compared with controls, LOAD cases showed significantly shorter telomeres. The association with disease risk was independent of confounders such as age, sex, Mini-Mental State Examination (MMSE), and Apolipoprotein E ε4 (APOE-ε4) status. Our findings support telomere shortening as a potential biomarker of LOAD risk. ABSTRACT: Telomeres are structures at the ends of eukaryotic chromosomes that help maintain genomic stability. During aging, telomere length gradually shortens, producing short telomeres, which are markers of premature cellular senescence. This may contribute to age-related diseases, including Alzheimer’s disease (AD), and based on this, several studies have hypothesized that telomere shortening may characterize AD. Current research, however, has been inconclusive regarding the direction of the association between leukocyte telomere length (LTL) and disease risk. We assessed the association between LTL and AD in a retrospective case–control study of a sample of 255 unrelated patients with late-onset AD (LOAD), including 120 sporadic cases and 135 with positive family history for LOAD, and a group of 279 cognitively healthy unrelated controls, who were all from Calabria, a southern Italian region. Following regression analysis, telomeres were found significantly shorter in LOAD cases than in controls (48% and 41% decrease for sporadic and familial cases, respectively; p < 0.001 for both). Interestingly, LTL was associated with disease risk independently of the presence of conventional risk factors (e.g., age, sex, MMSE scores, and the presence of the APOE-ε4 allele). Altogether, our findings lend support to the notion that LTL shortening may be an indicator of the pathogenesis of LOAD.
format Online
Article
Text
id pubmed-10604697
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106046972023-10-28 The Shortening of Leukocyte Telomere Length Contributes to Alzheimer’s Disease: Further Evidence from Late-Onset Familial and Sporadic Cases Crocco, Paolina De Rango, Francesco Dato, Serena La Grotta, Rossella Maletta, Raffaele Bruni, Amalia Cecilia Passarino, Giuseppe Rose, Giuseppina Biology (Basel) Article SIMPLE SUMMARY: Alzheimer’s disease (AD) is one of the most common forms of dementia in the aging population. The shortening of telomeres, which are complex structures at the ends of chromosomes, is considered one of the hallmarks of aging and has been implicated in several neurodegenerative diseases, especially AD, where the results are conflicting. Thus, to help clarify the association of telomere length with AD risk, leukocyte telomere length (LTL), measured as T/S ratio (telomere vs single-copy gene) was assessed in a cohort of 534 subjects, comprising sporadic and familial cases of late-onset AD (LOAD) and cognitively healthy controls. Compared with controls, LOAD cases showed significantly shorter telomeres. The association with disease risk was independent of confounders such as age, sex, Mini-Mental State Examination (MMSE), and Apolipoprotein E ε4 (APOE-ε4) status. Our findings support telomere shortening as a potential biomarker of LOAD risk. ABSTRACT: Telomeres are structures at the ends of eukaryotic chromosomes that help maintain genomic stability. During aging, telomere length gradually shortens, producing short telomeres, which are markers of premature cellular senescence. This may contribute to age-related diseases, including Alzheimer’s disease (AD), and based on this, several studies have hypothesized that telomere shortening may characterize AD. Current research, however, has been inconclusive regarding the direction of the association between leukocyte telomere length (LTL) and disease risk. We assessed the association between LTL and AD in a retrospective case–control study of a sample of 255 unrelated patients with late-onset AD (LOAD), including 120 sporadic cases and 135 with positive family history for LOAD, and a group of 279 cognitively healthy unrelated controls, who were all from Calabria, a southern Italian region. Following regression analysis, telomeres were found significantly shorter in LOAD cases than in controls (48% and 41% decrease for sporadic and familial cases, respectively; p < 0.001 for both). Interestingly, LTL was associated with disease risk independently of the presence of conventional risk factors (e.g., age, sex, MMSE scores, and the presence of the APOE-ε4 allele). Altogether, our findings lend support to the notion that LTL shortening may be an indicator of the pathogenesis of LOAD. MDPI 2023-09-26 /pmc/articles/PMC10604697/ /pubmed/37886996 http://dx.doi.org/10.3390/biology12101286 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Crocco, Paolina
De Rango, Francesco
Dato, Serena
La Grotta, Rossella
Maletta, Raffaele
Bruni, Amalia Cecilia
Passarino, Giuseppe
Rose, Giuseppina
The Shortening of Leukocyte Telomere Length Contributes to Alzheimer’s Disease: Further Evidence from Late-Onset Familial and Sporadic Cases
title The Shortening of Leukocyte Telomere Length Contributes to Alzheimer’s Disease: Further Evidence from Late-Onset Familial and Sporadic Cases
title_full The Shortening of Leukocyte Telomere Length Contributes to Alzheimer’s Disease: Further Evidence from Late-Onset Familial and Sporadic Cases
title_fullStr The Shortening of Leukocyte Telomere Length Contributes to Alzheimer’s Disease: Further Evidence from Late-Onset Familial and Sporadic Cases
title_full_unstemmed The Shortening of Leukocyte Telomere Length Contributes to Alzheimer’s Disease: Further Evidence from Late-Onset Familial and Sporadic Cases
title_short The Shortening of Leukocyte Telomere Length Contributes to Alzheimer’s Disease: Further Evidence from Late-Onset Familial and Sporadic Cases
title_sort shortening of leukocyte telomere length contributes to alzheimer’s disease: further evidence from late-onset familial and sporadic cases
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604697/
https://www.ncbi.nlm.nih.gov/pubmed/37886996
http://dx.doi.org/10.3390/biology12101286
work_keys_str_mv AT croccopaolina theshorteningofleukocytetelomerelengthcontributestoalzheimersdiseasefurtherevidencefromlateonsetfamilialandsporadiccases
AT derangofrancesco theshorteningofleukocytetelomerelengthcontributestoalzheimersdiseasefurtherevidencefromlateonsetfamilialandsporadiccases
AT datoserena theshorteningofleukocytetelomerelengthcontributestoalzheimersdiseasefurtherevidencefromlateonsetfamilialandsporadiccases
AT lagrottarossella theshorteningofleukocytetelomerelengthcontributestoalzheimersdiseasefurtherevidencefromlateonsetfamilialandsporadiccases
AT malettaraffaele theshorteningofleukocytetelomerelengthcontributestoalzheimersdiseasefurtherevidencefromlateonsetfamilialandsporadiccases
AT bruniamaliacecilia theshorteningofleukocytetelomerelengthcontributestoalzheimersdiseasefurtherevidencefromlateonsetfamilialandsporadiccases
AT passarinogiuseppe theshorteningofleukocytetelomerelengthcontributestoalzheimersdiseasefurtherevidencefromlateonsetfamilialandsporadiccases
AT rosegiuseppina theshorteningofleukocytetelomerelengthcontributestoalzheimersdiseasefurtherevidencefromlateonsetfamilialandsporadiccases
AT croccopaolina shorteningofleukocytetelomerelengthcontributestoalzheimersdiseasefurtherevidencefromlateonsetfamilialandsporadiccases
AT derangofrancesco shorteningofleukocytetelomerelengthcontributestoalzheimersdiseasefurtherevidencefromlateonsetfamilialandsporadiccases
AT datoserena shorteningofleukocytetelomerelengthcontributestoalzheimersdiseasefurtherevidencefromlateonsetfamilialandsporadiccases
AT lagrottarossella shorteningofleukocytetelomerelengthcontributestoalzheimersdiseasefurtherevidencefromlateonsetfamilialandsporadiccases
AT malettaraffaele shorteningofleukocytetelomerelengthcontributestoalzheimersdiseasefurtherevidencefromlateonsetfamilialandsporadiccases
AT bruniamaliacecilia shorteningofleukocytetelomerelengthcontributestoalzheimersdiseasefurtherevidencefromlateonsetfamilialandsporadiccases
AT passarinogiuseppe shorteningofleukocytetelomerelengthcontributestoalzheimersdiseasefurtherevidencefromlateonsetfamilialandsporadiccases
AT rosegiuseppina shorteningofleukocytetelomerelengthcontributestoalzheimersdiseasefurtherevidencefromlateonsetfamilialandsporadiccases